This multiomic solution targets DNA mutations (SNV, INDEL, FLT3 ITD, IGH Fusions, CNV) and chimeric RNA fusions, streamlining testing to under three days. The assay offers a future-proof solution by comprehensively targeting relevant mutation types across all heme-related genes. It also integrates automated laboratory and analysis solutions to ensure expedited reporting, minimizing the limitations of NGS testing.